Neurologists' decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices
{{output}}
The evolving landscape of generalised myasthenia gravis (gMG) treatment with new targeted immunotherapy options presents challenges for neurologists and potentially leads to therapeutic inertia (TI), the failure to initiate or intensify treatment when therapeu... ...
